+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Geriatric Medicines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4852053
  • Report
  • November 2018
  • Region: Global
  • 185 pages
  • Transparency Market Research
1 of 2

Global Geriatric Medicines Market: Overview

This report on the global geriatric medicines market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market value in terms of US$ Mn for each segment for the period from 2016 to 2026, considering the macro and micro environmental factors. Growth rates for each segment within the global geriatric medicines market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining expansion of the market and future opportunities has been provided in the market overview section. The report also provides insights into the key trends of the geriatric medicines market. The report includes market attractiveness analysis of the major geographic regions that provides a thorough analysis of the overall competitive scenario in the global geriatric medicines market.

Market value in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. The year-on-year growth of the global geriatric medicines market for each segment is also reflected. Additionally, market-related factors such as growing geriatric population, favorable government policies for elderly and developing healthcare infrastructure in emerging countries and historical year-on-year growth have been taken into consideration while estimating the market size.

Global Geriatric Medicines Market: Key Segments

The global geriatric medicines market has been segmented based on therapeutic category, condition, distribution channel, and region. In terms of therapeutic category, the geriatric medicine market has been divided into analgesic, antihypertensive, statins, antidiabetic, proton pump inhibitor, anticoagulant, antipsychotic & antidepressant, and others. In terms of condition, the market has been segregated into cardiovascular, arthritis, neurological, cancer, osteoporosis, respiratory, and others. In terms of distribution channel, the market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies.

Global Geriatric Medicines Market: Regional Outlook

In terms of region, the global geriatric medicines market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been further segmented into major countries in each of the regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia & New Zealand, Japan, India, Brazil, GCC, South Africa, and Mexico.

Companies Mentioned in Report

The report also profiles major players in the geriatric medicines market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Pfizer, Inc., Merck & Co., Inc., AstraZeneca, Bristol-Myers Squibb Company, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Abbott Laboratories, and Boehringer Ingelheim GmbH.

Note: Product cover images may vary from those shown
2 of 2
Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Geriatric Medicines Market Snapshot
3.2 Global Geriatric Medicines Market Share Analysis, by Region, 2017

Section 4 Market Overview
4.1 Global Geriatric Medicines Market Taxonomy
4.2 Global Geriatric Medicines Market Value (US$ Mn) Forecast, 2016-2026
4.3 Global Geriatric Medicines Market: Market Outlook
4.4 Key Industry Events

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.2.1 Increase in global geriatric population
5.2.2 Rise in chronic diseases (stroke, respiratory, and arthritis)
5.2.3 Increase in government support for elderly
5.2.4 Technological advancements for medication assistance
5.3 Restraints
5.3.1 Significant shortfall of geriatricians in the world
5.3.2 High chances of adverse drug reaction in elderly
5.3.3 Lack of patient participation in clinical trials

Section 6 Geriatric Medicines Market Analysis, by Therapeutic Category
6.1 Key Findings
6.2 Introduction
6.3 Global Geriatric Medicines Market Value Share Analysis, by Therapeutic Category
6.4 Global Geriatric Medicines Market Forecast, by Therapeutic Category
6.5 Global Geriatric Medicines Market Analysis, by Therapeutic Category
6.5.1 Analgesic
6.5.2 Antihypertensive
6.5.3 Statins
6.5.4 Antidiabetic
6.5.5 Proton Pump Inhibitor
6.5.6 Anticoagulant
6.5.7 Antipsychotic and Antidepressant
6.5.8 Others

Section 7 Global Geriatric Medicines Market Analysis, by Condition
7.1 Key Findings
7.2 Introduction
7.3 Global Geriatric Medicines Market Value Share Analysis, by Condition
7.4 Global Geriatric Medicines Market Forecast, by Condition
7.5 Global Geriatric Medicines Market Analysis, by Condition
7.5.1 Cardiovascular
7.5.2 Arthritis
7.5.3 Diabetes
7.5.4 Neurological
7.5.5 Cancer
7.5.6 Osteoporosis
7.5.7 Respiratory
7.5.8 Others

Section 8 Global Geriatric Medicines Market Analysis, by Distribution Channel
8.1 Key Findings
8.2 Introduction
8.3 Global Geriatric Medicines Market Value Share Analysis, by Distribution Channel
8.4 Global Geriatric Medicines Market Forecast, by Distribution Channel
8.5 Global Geriatric Medicines Market Analysis, by Distribution Channel
8.5.1 Hospital Pharmacies
8.5.2 Retail Pharmacies
8.5.3 Online Pharmacies

Section 9 Global Geriatric Medicines Market Analysis, by Region
9.1 Global Geriatric Medicines Market Value Share Analysis, by Region
9.2 Global Geriatric Medicines Market Forecast, by Region

Section 10 North America Geriatric Medicines Market Analysis, by Region
10.1 Market Overview
10.2 North America Geriatric Medicines Market Value Share and Attractiveness Analysis, by Country
10.3 North America Geriatric Medicines Market Value Share Analysis, by Therapeutic Category
10.4 North America Geriatric Medicines Market Forecast, by Therapeutic Category
10.5 North America Geriatric Medicines Market Value Share Analysis, by Condition
10.6 North America Geriatric Medicines Market Forecast, by Condition
10.7 North America Geriatric Medicines Market Value Share Analysis, by Distribution Channel
10.8 North America Geriatric Medicines Market Forecast, by Distribution Channel
10.9 North America Geriatric Medicines Market Value Share Analysis, by Country
10.10 North America Geriatric Medicines Market Forecast, by Country
10.10.1 U.S.
10.10.2 Canada

Section 11 Europe Geriatric Medicines Market Analysis, by Region
11.1 Market Overview
11.2 Europe Geriatric Medicines Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3 Europe Geriatric Medicines Market Value Share Analysis, by Therapeutic Category
11.4 Europe Geriatric Medicines Market Forecast, by Therapeutic Category
11.5 Europe Geriatric Medicines Market Value Share Analysis, by Condition
11.6 Europe Geriatric Medicines Market Forecast, by Condition
11.7 Europe Geriatric Medicines Market Value Share Analysis, by Distribution Channel
11.8 Europe Geriatric Medicines Market Forecast, by Distribution Channel
11.9 Europe Geriatric Medicines Market Value Share Analysis, by Country/Sub-region
11.10 Europe Geriatric Medicines Market Forecast, by Country/Sub-region
11.10.1 Germany
11.10.2 U.K.
11.10.3 France
11.10.4 Spain
11.10.5 Italy
11.10.6 Rest of Europe

Section 12 Asia Pacific Geriatric Medicines Market Analysis, by Region
12.1 Market Overview
12.2 Asia Pacific Geriatric Medicines Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3 Asia Pacific Geriatric Medicines Market Value Share Analysis, by Therapeutic Category
12.4 Asia Pacific Geriatric Medicines Market Forecast, by Therapeutic Category
12.5 Asia Pacific Geriatric Medicines Market Value Share Analysis, by Condition
12.6 Asia Pacific Geriatric Medicines Market Forecast, by Condition
12.7 Asia Pacific Geriatric Medicines Market Value Share Analysis, by Distribution Channel
12.8 Asia Pacific Geriatric Medicines Market Forecast, by Distribution Channel
12.9 Asia Pacific Geriatric Medicines Market Value Share Analysis, by Country/Sub-region
12.10 Asia Pacific Geriatric Medicines Market Forecast, by Country/Sub-region
12.10.1 China
12.10.2 Japan
12.10.3 India
12.10.4 Australia & New Zealand
12.10.5 Rest of APAC

Section 13 Latin America Geriatric Medicines Market Analysis, by Region
13.1 Market Overview
13.2 Latin America Geriatric Medicines Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3 Latin America Geriatric Medicines Market Value Share Analysis, by Therapeutic Category
13.4 Latin America Geriatric Medicines Market Forecast, by Therapeutic Category
13.5 Latin America Geriatric Medicines Market Value Share Analysis, by Condition
13.6 Latin America Geriatric Medicines Market Forecast, by Condition
13.7 Latin America Geriatric Medicines Market Value Share Analysis, by Distribution Channel
13.8 Latin America Geriatric Medicines Market Forecast, by Distribution Channel
13.9 Latin America Geriatric Medicines Market Value Share Analysis, by Country/Sub-region
13.10 Latin America Geriatric Medicines Market Forecast, by Country/Sub-region
13.10.1 Brazil
13.10.2 Mexico
13.10.3 Rest of LATAM

Section 14 Middle East & Africa Geriatric Medicines Market Analysis, by Region
14.1 Market Overview
14.2 Middle East & Africa Geriatric Medicines Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3 Middle East & Africa Geriatric Medicines Market Value Share Analysis, by Therapeutic Category
14.4 Middle East & Africa Geriatric Medicines Market Forecast, by Therapeutic Category
14.5 Middle East & Africa Geriatric Medicines Market Value Share Analysis, by Condition
14.6 Middle East & Africa Geriatric Medicines Market Forecast, by Condition
14.7 Middle East & Africa Geriatric Medicines Market Value Share Analysis, by Distribution Channel
14.8 Middle East & Africa Geriatric Medicines Market Forecast, by Distribution Channel
14.9 Middle East & Africa Geriatric Medicines Market Value Share Analysis, by Country/Sub-region
14.10 Middle East & Africa Geriatric Medicines Market Forecast, by Country/Sub-region
14.10.1 GCC
14.10.2 South Africa
14.10.3 Rest of MEA

Section 15 Company Profiles
15.2.1 Pfizer, Inc.
15.2.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2 Financial Overview
15.2.1.3 Product Portfolio
15.2.1.4 SWOT Analysis
15.2.1.5 Strategic Overview
15.2.2 Merck & Co., Inc.
15.2.2.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2 Financial Overview
15.2.2.3 Product Portfolio
15.2.2.4 SWOT Analysis
15.2.2.5 Strategic Overview
15.2.3 AstraZeneca
15.2.3.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2 Financial Overview
15.2.3.3 Product Portfolio
15.2.3.4 SWOT Analysis
15.2.3.5 Strategic Overview
15.2.4 Bristol-Myers Squibb Company
15.2.4.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2 Financial Overview
15.2.4.3 Product Portfolio
15.2.4.4 SWOT Analysis
15.2.4.5 Strategic Overview
15.2.5 Novartis AG
15.2.5.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2 Financial Overview
15.2.5.3 Product Portfolio
15.2.5.4 SWOT Analysis
15.2.5.5 Strategic Overview
15.2.6 Sanofi S.A.
15.2.6.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2 Financial Overview
15.2.6.3 Product Portfolio
15.2.6.4 SWOT Analysis
15.2.6.5 Strategic Overview
15.2.7 GlaxoSmithKline plc
15.2.7.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2 Financial Overview
15.2.7.3 Product Portfolio
15.2.7.4 SWOT Analysis
15.2.7.5 Strategic Overview
15.2.8 Eli Lilly and Company
15.2.8.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2 Financial Overview
15.2.8.3 Product Portfolio
15.2.8.4 SWOT Analysis
15.2.8.5 Strategic Overview
15.2.9 Abbott Laboratories
15.2.9.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2 Financial Overview
15.2.9.3 Product Portfolio
15.2.9.4 SWOT Analysis
15.2.9.5 Strategic Overview
15.2.10 Boehringer Ingelheim GmbH
15.2.10.1 Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2 Financial Overview
15.2.10.3 Product Portfolio
15.2.10.4 SWOT Analysis
15.2.10.5 Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll